First Trust Advisors LP Iveric Bio, Inc. Transaction History

First Trust Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $166,414 - $251,333	6,342 New	6,342 $249,000
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $1.51 Million - $3.73 Million	-213,109 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $34,191 - $43,084	-6,009 Reduced 2.74%	213,109 $1.35 Million
Q1 2021 May 14, 2021	BUY	$5.08 - $6.89 $89,347 - $121,181	17,588 Added 8.73%	219,118 $1.35 Million
Q4 2020 Feb 02, 2021	SELL	$5.65 - $7.66 $50,590 - $68,587	-8,954 Reduced 4.25%	201,530 $1.39 Million
Q3 2020 Nov 05, 2020	BUY	$4.01 - $6.29 $844,040 - $1.32 Million	210,484 New	210,484 $1.19 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.